Q-linea AB (OSTO:QLINEA) Marketable Securities : kr0.00 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Q-linea AB Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Q-linea AB's Marketable Securities for the quarter that ended in Sep. 2024 was kr0.00 Mil.

Q-linea AB's annual Marketable Securities declined from Dec. 2021 (kr150.72 Mil) to Dec. 2022 (kr0.00 Mil) but then stayed the same from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil).

Q-linea AB Marketable Securities Historical Data

The historical data trend for Q-linea AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q-linea AB Marketable Securities Chart

Q-linea AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

180.51

297.08

150.72

Q-linea AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Marketable Securities	Get a 7-Day Free Trial															79.75	-	-	-	-

Q-linea AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Q-linea AB (OSTO:QLINEA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Q-linea AB Marketable Securities Related Terms

Thank you for viewing the detailed overview of Q-linea AB's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Q-linea AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Q-linea AB (OSTO:QLINEA) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

3F8:Germany

Address

Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37

Website

https://www.qlinea.com

Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.

Q-linea AB Headlines

No Headlines